Ask A Doc: Dr. Joseph Bennett talks new technology for early lung cancer detection - CBS News
Ask A Doc: Dr. Joseph Bennett talks new technology for early lung cancer detection CBS News
Ask A Doc: Dr. Joseph Bennett talks new technology for early lung cancer detection CBS News
How Recent Lung Cancer FDA Approvals are Shaping Treatment for Patients Cure Today
Dear Doctor: Reader was ‘scared to death’ over recent comment Dr. Roach made in cancer column OregonLive.com
Candel Therapeutics reports extended survival in Phase 2a lung cancer trial of CAN-2409 Yahoo Finance
Tissue Microarray Analysis Reveals Heterogeneous Expression of Talin-1 and Lactate Dehydrogenase A in Non-small Cell Lung Cancer: Implications for Biomarker Reliability Cureus
Ask A Doc: Dr. Joseph Bennett discusses new technology for early lung cancer detection CBS News
Severe COVID or flu may raise lung cancer risk years later ScienceDaily
How tumours trick the brain into shutting down cancer-fighting cells Nature
Some Immune Systems Defeat Cancer. Could That Become a Drug? The New York Times
A toxic gas was hiding inside his home for decades. It's radon, and scientists are tackling its deadly rise | CBC News CBC
Non-Smokers and Lung Cancer: Uncovering the Truth OSF HealthCare
Memorial Health System adds Ion robot to detect, treat lung cancer earlier WLOX
Computational pathology features of immune architecture predict clinically relevant outcomes in small-cell lung cancer (SCLC) Nature
Ballad Health to offer free lung cancer screenings WJHL
Mayo Clinic study finds lung cancer drug shows promise for ovarian cancer treatment KTTC | Rochester, MN
Memorial Hospital adds Ion robot to detect, treat lung cancer earlier WECT
Which Patients Benefit Most From Tarlatamab (Imdelltra) for SCLC? Oncology News Central
A video summary of the DeLLphi-301 study: tarlatamab as a treatment option for small cell lung cancer Oncology Central
Med Uni Graz and Boehringer Ingelheim Open Lung Cancer Research Lab PharmTech.com
Blocking lipid production in healthy lung cells can reduce lung metastasis Medical Xpress
Severe COVID-19 Linked to Higher Lung Cancer Risk European Medical Journal
Phase 3 Trial of Eftilagimod Alfa in First-Line NSCLC Is Halted After Futility Analysis Targeted Oncology
Harvard Medical School professor and ONU alumna Dr. Carla Kim to deliver 2026 Keiser Lecture Ohio Northern University
Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026 PR Newswire
Early diagnosis and local solutions are critical to combat lung cancer Devex
How Recent FDA Approvals Are Changing Lung Cancer Treatment(1)_1 Cure Today
Memorial Hospital adds Ion robot to detect, treat lung cancer earlier WLOX
Mayo Clinic study finds lung cancer drug shows promise for ovarian cancer treatment KTTC | Rochester, MN
Candel Therapeutics reports extended survival in Phase 2a lung cancer trial of CAN-2409 Proactive financial news
Can AI Clarify Lung Screening? Conexiant
Lung Cancer Group Outlines How 2026 EPA Actions Could Shape Asbestos-Related Lung Cancer Claims Yahoo Finance
QVT Score In NSCLC Immunotherapy: A New Imaging Biomarker For Prognosis And Early Response Monitoring Oncodaily
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures Yahoo Finance UK
Surgery in Octogenarians With Early-Stage NSCLC: What This Prospective Study Shows About Safety, Survival, And Quality Of Life Oncodaily
Ion robotic bronchoscopy transforms lung cancer detection Lawrence Journal-World
Vergent Bioscience Initiates Phase 3 VISUALIZE 2 Pivotal Study of Abenacianine (VGT-309) for Tumor Visualization During Lung Cancer Surgery Yahoo Finance
Takeda Tracks Real-World Safety of Alunbrig in Japanese Lung Cancer Patients TipRanks
Immutep completely tanks after discontinuing lung cancer drug trial Mugglehead Investment Magazine
Could Targeting Supra-Carcinoids be the Future of Lung NET Research? CancerNetwork
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung Business Wire